References
- J. Neyts, G. Andrei and E. De Clercq, The novel immuno- suppressive agent mycophenolate mofetil markedly poten- tiates the antiherpesvirus activities of acyclovir, gancyclovir, and penciclovir in vitro and in vivo, Antimicrob. Agents Chemother., 181, 216-222 (1998)
- F.G. Hayden, Antimicrobial Agents: In The Pharmacological Basis of Therapeutics, J.G. Hardman, L.E. Limbird and A.G. Gilman (Ed.), McGraw-Hill, New York, USA, pp. 1317-1322 (2001)
- M. Ishida, N. Nambu, and T. Nagai, Mucosal dosage form of lidocaine for toothache using hydroxypropyl cellulose and Carbopol, Chem. Pharm. Bull., 30, 980-984 (1982) https://doi.org/10.1248/cpb.30.980
- A.D. Woolfson, D.F. McCafferty and V. Boston, Clinical experiences with a novel percutaneous amethocaine prepara- tion: prevention of pain due to venepuncture in children, Br. J. Clin. Pharmacol., 30, 273-279 (1990) https://doi.org/10.1111/j.1365-2125.1990.tb03775.x
- A.D. Woolfson, D.F. McCafferty and G.P. Moss, Develop- ment and characterization of a moisture-activated bioad- hesive drug delivery system for percutaneous local anaes- thesia, Int. J. Pharm., 169, 83-94 (1998) https://doi.org/10.1016/S0378-5173(98)00109-4
- D.F. McCafferty and A.D. Woolfson, New patch delivery system for percutaneous local anaesthesia, Br. J. Anaesth., 71, 370-374 (1993) https://doi.org/10.1093/bja/71.3.370
- D.F. McCafferty, A.D. Woolfson and G.P. Moss, Novel bioadhesive delivery system for percutaneous local anaesthesia, Br. J. Anaesth., 84, 456-458 (2000) https://doi.org/10.1093/oxfordjournals.bja.a013469
- E. Sozen, A.M. Avunduk and N. Akyol, Comparison of efficacy of oral valacyclovir and topical acyclovir in the treatment of herpes simplex keratitis: a randomized clinical trial, Chemotherapy, 52, 29-31 (2006) https://doi.org/10.1159/000090239
- S.A. Qureshi, M. Jiang, K.K. Midha and J.P. Skelly, In vitro evaluation of percutaneous absorption of an acyclovir product using intact and tape-stripped human skin, J. Pharm. Pharm. Sci., 1, 102-107 (1998)
- G.R. Kinghorn, Topical acyclovir in the treatment of recurrent herpes simplex virus infections, Scand. J. Infect. Dis. Suppl., 47, 58-62 (1985)
- M. Ishida, Y. Machida, N. Nambu and T. Nagai, New mucosal dosage form of insulin, Chem. Pharm. Bull., 29, 810-816 (1981) https://doi.org/10.1248/cpb.29.810
- T. Nagai, Topical mucosal adhesive dosage forms, Med. Res. Rev., 6, 227-242 (1986) https://doi.org/10.1002/med.2610060205
- Y.W. Chien and H.J. Lambert, Controlled drug release from polymeric delivery devices. II. Differentiation between partition-controlled and matrix-controlled drug release mechanism, J. Pharm. Sci., 63, 515-519 (1974) https://doi.org/10.1002/jps.2600630405
- A.C. Williams and B.W. Barry, Terpenes and the lipid-protein partitioning theory of skin penetration enhancement, Pharm. Res., 8, 17-24 (1991) https://doi.org/10.1023/A:1015813803205